Steroid Injection for Post-Spinal Fusion Pain Management
(SFSS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether a steroid injection called dexamethasone can reduce pain and the need for opioid medications after spinal surgery in children with spine deformity. The study aims to determine if this treatment eases recovery by decreasing pain, speeding up walking after surgery, and shortening hospital stays. Participants will receive either the steroid injection or a placebo (a harmless saline solution) for comparison. Children undergoing their first spinal fusion surgery for scoliosis (a spine curve) may qualify for this trial, provided there is parental consent. As an Early Phase 1 trial, this research focuses on understanding how the treatment works in people, offering participants the chance to contribute to groundbreaking medical knowledge.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this treatment is likely to be safe for humans?
Research has shown that administering dexamethasone through an IV can help reduce pain after surgery. Some studies suggest it can also lower the need for opioids, which are addictive pain medications. For instance, a review of several studies found that a moderate dose of dexamethasone led to less opioid use and reduced pain after surgery. Another study found that dexamethasone improved pain relief after spinal anesthesia.
However, the results are not always positive. In larger surgeries, dexamethasone did not consistently reduce the need for pain medication. Concerns exist about its impact on wound healing and the risk of infection, especially in spine surgeries. Yet, in children and teens undergoing surgery for spine deformities, dexamethasone was linked to reduced opioid use without increasing the risk of complications.
This trial is in the early testing stages, so limited information is available on its safety for this specific use. However, dexamethasone is already used for other conditions, suggesting it is generally well-tolerated.12345Why do researchers think this study treatment might be promising?
Most treatments for post-spinal fusion pain typically involve oral medications like opioids or NSAIDs. Dexamethasone injection is unique because it delivers a targeted steroid directly to the surgical site, potentially reducing inflammation more effectively than systemic medications. This local delivery method could mean quicker pain relief with fewer side effects. Researchers are excited about this treatment as it offers a promising alternative that can enhance recovery and improve patient comfort following spinal fusion surgery.
What evidence suggests that this treatment might be an effective treatment for post-spinal fusion pain?
Research has shown that administering dexamethasone through an IV can reduce pain after surgery. In one study, 74.8% of patients who received dexamethasone rated their pain relief as "Excellent" following spinal surgery. Another study found that dexamethasone significantly reduces the need for opioids and lowers pain levels post-surgery. However, concerns exist about side effects, such as wound healing issues and an increased risk of infection. Despite these concerns, early evidence suggests that dexamethasone might ease post-surgery pain and facilitate smoother recovery. In this trial, participants will receive either a steroid injection with dexamethasone or a placebo comparator with saline solution to evaluate the effectiveness and safety of dexamethasone for managing post-spinal fusion pain.14678
Are You a Good Fit for This Trial?
This trial is for children who need surgery for spine deformity and have their parents' consent. They must be having a first-time spinal fusion surgery, not a revision procedure, and shouldn't have other conditions that could affect recovery.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Perioperative Treatment
Dexamethasone or saline is administered intraoperatively and post-operatively to manage pain and reduce opioid use
Follow-up
Participants are monitored for safety and effectiveness after treatment, including pain scores and morphine equivalent use
Extended Follow-up
Participants are tracked for return to emergency department and return to school
What Are the Treatments Tested in This Trial?
Interventions
- Dexamethasone injection
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Texas at Austin
Lead Sponsor